Home sales rise 1.5% in September as mortgage rates dip
Home sales increased 1.5% in September as mortgage rates dipped, according to the National Association of Realtors.
The group said September’s 1.5% increase in existing-home sales put sales on a seasonally adjusted annual rate of 4.06 million in September. It also reported a 1.3% increase in unsold inventory to 1.55 million units, equal to 4.6 months’ supply. Six months worth of supply is generally considered a balanced market.
“As anticipated, falling mortgage rates are lifting home sales,” NAR Chief Economist Dr. Lawrence Yun said. “Improving housing affordability is also contributing to the increase in sales.”
Year-over-year, existing home sales were up 4.1%. Prices were up as well.
Existing home sales gained 2.1%, pushing the median existing-home sales price to $415,200. That’s the 27th consecutive month of year-over-year price increases.
“Inventory is matching a five-year high, though it remains below pre-COVID levels,” Yun said. “Many homeowners are financially comfortable, resulting in very few distressed properties and forced sales. Home prices continue to rise in most parts of the country, further contributing to overall household wealth.”
The average 30-year fixed-rate mortgage in September was 6.35%, according to Freddie Mac. That’s down from 6.59% in August and up from 6.18% one year ago.
Latest News Stories
Experts dispute Arizona governor’s claims about state-funded school choice program
DOJ claims ‘substantial progress’ made on Epstein files, but no new releases
Trump eyes tariffs to pressure Greenland
Group wants records on Minnesota child care assistance program
WATCH: Ives investigates tax dollars for NGOs; Republicans say Pritzker raising energy prices
ICE hiring ban bill reignites SAFE-T Act fight at Illinois Capitol
Illinois Quick Hits: OIG recommends firing 5 employees
Firms team up with states to scrutinize health care spending
St. Paul students marked absent after protests against ICE
Poll: Trump’s approval rating falls 16% in Arizona
SCOTUS to consider second election law case
Medical device manufacturer invests $110M to expand Nebraska plant, boost drug supply